Avidity Biosciences, Inc.
RNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,245 | $661 | $1,157 | $985 |
| - Cash | $220 | $185 | $340 | $320 |
| + Debt | $7 | $10 | $11 | $12 |
| Enterprise Value | $3,032 | $486 | $828 | $676 |
| Revenue | $11 | $10 | $9 | $9 |
| % Growth | 14% | 3.6% | -1.1% | – |
| Gross Profit | $11 | $7 | $8 | -$92 |
| % Margin | 100% | 78% | 85% | -984.9% |
| EBITDA | -$376 | -$233 | -$178 | -$117 |
| % Margin | -3,452% | -2,442.4% | -1,924.6% | -1,259% |
| Net Income | -$322 | -$212 | -$174 | -$118 |
| % Margin | -2,957.7% | -2,219.9% | -1,886.3% | -1,265.4% |
| EPS Diluted | -2.89 | -2.91 | -3.34 | -2.85 |
| % Growth | 0.7% | 12.9% | -17.2% | – |
| Operating Cash Flow | -$301 | -$119 | -$136 | -$95 |
| Capital Expenditures | -$7 | -$4 | -$3 | -$4 |
| Free Cash Flow | -$308 | -$123 | -$139 | -$99 |